MarketPulse — Real-Time Financial News & Market Analysis

Oracle stock fell 18% in 2026 despite record results; JPMorgan upgraded shares to Overweight with $210 target, citing attractive valuation after sell-off.

Occidental Petroleum rose 9% while Brent crude surged 70% on Iran tensions, signaling market skepticism about sustained high prices due to U.S. strategic reserves and Strait of Hormuz stabilization efforts.

Carvana surged 440% from near-bankruptcy to record 2024 results: 43% unit growth, $20.3B revenue. With just 1.6% market share, analysts see significant upside ahead.

Class action lawsuit filed against $QURE over alleged misstatements about Huntington's disease therapy approval timeline. Stock crashed 49% after FDA stance shift.

Rosen Law Firm urges PomDoctor Ltd. investors to join securities class action before April 7, 2026 deadline. Allegations include false statements, insider dumping, and artificial trading schemes.

TJX Companies and Deckers Outdoor offer compelling long-term growth at reasonable valuations outside crowded tech sector, with TJX showing 5% sales growth and Deckers trading below historical multiples.

Conagra invests $220M in chicken processing despite 6.8% Q2 sales decline and brand write-downs, raising questions about the investment's strategic timing.

AMD challenges Nvidia with MI450 chip and Meta partnership, projecting 35% revenue growth at attractive 31x forward P/E valuation.

Class action lawsuit filed against monday.com alleging false revenue and growth statements from September 2025 to February 2026. Investors urged to participate in suit.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to join.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production delays, battery quality issues, and false guidance during November 2025-February 2026 period.

Class action filed against $AMC alleging securities fraud over APE preferred equity units being excluded from special dividend after conversion to common stock.

Trip.com faces class action alleging false statements about regulatory risks tied to monopolistic practices, covering investors from April 2024 to January 2026.

Schwab's dividend-growth ETF $SCHD significantly outperforms high-yield competitor $DIV, delivering 11% vs. 3.9% annualized returns, highlighting quality's advantage over yield chasing.

Blue Door invests $16M in NICE stock despite 17% decline, betting on 8% revenue growth, 13% cloud expansion, and 43% EPS acceleration driven by AI adoption.

Bitcoin's 236% three-year return beats index funds' 10.7%, but S&P 500 funds suit most $1,500 investors for stability and diversification.

Waystar's stock fell 32% over a year, but Blue Door Asset Management bought $11.49M in shares, betting on the healthcare software company's strong fundamentals: 17% revenue and 21% EBITDA growth.

Ethereum's technical roadmap upgrades and anticipated staking ETF approvals in late 2025 could drive multibagger returns over a decade, though analysts caution gains may not match prior cycles.

Coca-Cola and Procter & Gamble attract investors as defensive plays, boasting 64 and 69 consecutive years of dividend increases respectively.

Ten major companies suffered steep declines during March 9-13, led by Fair Isaac's 21.59% drop following a debt offering announcement.